Teva Pharmaceuticals (TEVA) said it has agreed to buy the generic drug business of Allergan (ACT) for $40.5 billion as emerging markets spend more on prescription drugs and more Americans gain health coverage and look for cheaper medicines.
Sourced through Scoop.it from: www.forbes.com
Kenneth Carnesi holds a Juris Doctor degree from New York Law School and a Professional Certificate in International Banking from Harvard Law School. Kenneth Carnesi is the Director of Operations and Government Sales at Anaptyx LLC and sits on the Boards of The Lazarus Organization, Monkeetech LLC and MG Madison Phillips, Inc. Mr. Carnesi has also founded CICG - Carnesi International Consulting Group, a company specializing in strategy consulting to small to mid-size businesses.
Kenneth Carnesi 
Leave a comment